• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transbound Emerg Dis . Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals

tetano

Editor, Senior Moderator
Transbound Emerg Dis


. 2020 Nov 15.
doi: 10.1111/tbed.13926. Online ahead of print.
Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals


Kerstin Wernike[SUP] 1 [/SUP], Andrea Aebischer[SUP] 1 [/SUP], Anna Michelitsch[SUP] 1 [/SUP], Donata Hoffmann[SUP] 1 [/SUP], Conrad Freuling[SUP] 1 [/SUP], Anne Balkema-Buschmann[SUP] 1 [/SUP], Annika Graaf[SUP] 1 [/SUP], Thomas M?ller[SUP] 1 [/SUP], Nikolaus Osterrieder[SUP] 2 3 [/SUP], Melanie Rissmann[SUP] 1 [/SUP], Dennis Rubbenstroth[SUP] 1 [/SUP], Jacob Sch?n[SUP] 1 [/SUP], Claudia Schulz[SUP] 4 [/SUP], Jakob Trimpert[SUP] 2 [/SUP], Lorenz Ulrich[SUP] 1 [/SUP], Asisa Volz[SUP] 4 [/SUP], Thomas Mettenleiter[SUP] 1 [/SUP], Martin Beer[SUP] 1 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic with millions of infected humans and hundreds of thousands of fatalities. As the novel disease - referred to as COVID-19 - unfolded, occasional anthropozoonotic infections of animals by owners or caretakers were reported in dogs, felid species and farmed mink. Further species were shown to be susceptible under experimental conditions. The extent of natural infections of animals, however, is still largely unknown. Serological methods will be useful tools for tracing SARS-CoV-2 infections in animals once test systems are evaluated for use in different species. Here, we developed an indirect multi-species ELISA based on the receptor-binding domain (RBD) of SARS-CoV-2. The newly established ELISA was evaluated using 59 sera of infected or vaccinated animals including ferrets, raccoon dogs, hamsters, rabbits, chickens, cattle and a cat, and a total of 220 antibody-negative sera of the same animal species. Overall, a diagnostic specificity of 100.0% and sensitivity of 98.31% was achieved, and the functionality with every species included in this study could be demonstrated. Hence, a versatile and reliable ELISA protocol was established that enables high-throughput antibody detection in a broad range of animal species, which may be used for outbreak investigations, to assess the seroprevalence in susceptible species or to screen for reservoir or intermediate hosts.

Keywords: COVID-19; SARS-CoV-2; animals; cattle; chicken; diagnostics; felines; mustelids; raccoon dog; serology.
 
Back
Top Bottom